Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase
Reexamination Certificate
2005-03-24
2009-12-29
Weber, Jon P (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving oxidoreductase
C435S189000
Reexamination Certificate
active
07638295
ABSTRACT:
A method of identifying an agent which modulates 2-oxoglutarate dependent oxygenase activity, the method comprising contacting a 2-oxoglutarate dependent oxygenase and a test agent in the presence of a substrate comprising one or more ankyrin repeat, or fragment thereof, in conditions under which the substrate is hydroxylated in the absence of the test agent; and determining hydroxylation of the substrate.
REFERENCES:
patent: 4446038 (1984-05-01), Schlicht et al.
patent: 5206343 (1993-04-01), Henke et al.
patent: 5916898 (1999-06-01), Edwards et al.
patent: 6200974 (2001-03-01), Edwards et al.
patent: 6566088 (2003-05-01), McKnight et al.
patent: 2003/0153503 (2003-08-01), Klaus et al.
patent: 2003/0176317 (2003-09-01), Guenzler-Pukall et al.
patent: 2004/0053977 (2004-03-01), Almstead et al.
patent: WO 02/074981 (2002-09-01), None
patent: 03/080566 (2003-10-01), None
patent: WO 03/100087 (2003-12-01), None
patent: WO 03/100438 (2003-12-01), None
patent: 2004/035812 (2004-04-01), None
Wells, J.A. Additivity of Mutational Effects in Proteins; Biochemistry, vol. 29, No. 37 (1990) pp. 8509-8517.
Seffernick et al. Melamine Deaminase and Atrazine Chlorohydrolase: 98 Percent identical but Functionally Different; Journal of Bacteriology, vol. 183, No. 8 (2001) pp. 2405-2410.
Ciechanover et al., “Mechanisms of Ubiquitin-Mediated, Limited Processing of the NF-kappaB1 Precursor Protein p105,” Biochimie 83:341-349, 2001.
Dann et al., “Structure of Factor-Inhibiting Hypoxia-Inducible Factor 1: an Asparaginyl Hydroxylase Involved in the Hypoxic Response Pathway,” PNAS 99:15351-15356, 2002.
Elkins et al., “Structure of Factor-Inhibiting Hypoxia-Inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1alpha,” J. Biol. Chem. 278:1802-1806, 2003.
Hewitson et al., “The Role of Iron and 2-Oxoglutarate Oxygenases in Signalling,” Biochem. Soc. Trans. 31:510-515, 2003.
Lee et al., “Structure of Human FIH-1 Reveals a Unique Active Site Pocket and Interaction Sites for HIF-1 and von Hippel-Lindau,” J. Biol. Chem. 278:7558-7563, 2003.
Mole et al., “2-Oxoglutarate Analogue Inhibitors of HIF Prolyl Hydroxylase,” Bioorg. Med. Chem. Lett. 13:2677-2680, 2003.
Sedgwick et al., “The Ankyrin Repeat: a Diversity of Interactions on a Common Structural Framework,” Trends Biochem. Sci. 24:311-316, 1999.
Asikainen et al., “Stabilization of HIF-1Alpha and Release of VEGF by Prolyl-4-Hydroxylase Inhibition in Human Lung Cells,” Free Radical Bio. Med. 35:410 Suppl. 1, 2003.
Aoyagi et al., “Prolyl 4-Hydroxylase Inhibitor is More Effective for the Inhibition of Proliferation than for Inhibition of Collagen Synthesis of Rat Hepatic Stellate Cells,” Hepatol. Res. 23:1-6, 2002.
Baader et al., “Inhibition of Prolyl 4-Hydroxylase by Oxalyl Amino Acid Derivatives in vitro, in Isolated Microsomes and in Embryonic Chicken Tissues,” Biochem. J. 300:525-530, 1994.
Baader et al., “Interference in Clinical Laboratory Tests, with Special Regard to the Bilirubin Assay: Effects of a Metabolite of the New Prolyl 4-Hydroxylase Inhibitor, Lufironil,” Eur. J. Clin. Chem. Clin. Biol. 32:515-520, 1994.
Bickel et al., “Beneficial Effects of Inhibitors of Prolyl 4-Hydroxylase in CCI4-Induced Fibrosis of the Liver in Rats,” J. Hepatol. 13(Suppl. 3):S26-S34, 1991.
Bickel et al., “Selective Inhibition of Hepatic Collagen Accumulation in Experimental Liver Fibrosis in Rats by a New Prolyl 4-Hydroxylase Inhibitor,” Hepatol. 28:404-411, 1998.
Cunliffe et al., “Inhibition of Prolyl 4-Hydroxylase by Hydroxyanthraquinones,” Biochem. J. 239:311-315, 1986.
Cunliffe et al., “Novel Inhibitors of Prolyl 4-Hydroxylase 3.1Inhibition by the Substrate AnalogueN-Oxaloglycine and Its Derivatives,” J. Med. Chem. 35:2652-2658, 1992.
Dowell et al., “Novel Inhibitors of Prolyl 4-Hydroxylase, Part 4. Pyridine-2-Carboxylic Acid Analogues with Alternative 2-Substituents,” Eur. J. Med. Chem. 28:513-516, 1993.
Franklin et al., “Inhibition of Collagen Hydroxylation by 2,7,8-Trihydroxyanthraquinone in Embryonic-Chick Tendon Cells,” Biochem. J. 261:127-130, 1989.
Franklin et al., “Therapeutic Approaches to Organ Fibrosis,” Int. J. Biochem. Cell Biol. 29:79-89, 1997.
Franklin et al., “Inhibition of Prolyl 4-Hydroxylase in vitro and in vivo by Members of a Novel Series of Phenanthrolinones,” Biochem. J. 353:333-338, 2001.
Friedman et al., “Prolyl 4-Hydroxylase is Required for Viability and Morphogenesis inCaenorhabditis elegans,” Proc. Natl. Acad. Sci. U.S.A. 97:4736-4741, 2000.
Hewitson et al., “Hypoxia-Inducible Factor (HIF) Asparagine Hydroxylase is Identical to Factor Inhibiting HIF (FIH) and is Related to the Cupin Structural Family,” J. Biol. Chem. 277:26351-26355, 2002.
Higashide et al., “Alahopcin, a New Dipeptide Antibiotic Produced byStreptomyces albulusSubsp.OchragerusSubsp. Nov.,” J. Antibiot. 38:285-295, 1985.
Ivan et al., “Biochemical Purification and Pharmacological Inhibition of a Mammalian Prolyl Hydroxylase Acting on Hypoxia-Inducible Factor,” Proc. Natl. Acad. Sci. U.S.A. 99:13459-13464, 2002.
Lerner et al., “X-Ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-Methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity,” Angew. Chem. Int. Ed. 40:4040-4042, 2001.
Mahon et al., “FIH-1: A Novel Protein that Interacts with HIF-1α and VHL to Mediate Repression of HIF-1 Transcriptional Activity,” Genes Dev. 15:2675-2686, 2001.
Main et al., “The Folding and Design of Repeat Proteins: Reaching a Consensus,” Curr. Opin. Struct. Biol. 13:482-489, 2003.
McNeill et al., “A Fluorescence-Based Assay for 2-Oxoglutarate-Dependent Oxygenases,” Anal. Biochem. 336:125-131, 2005.
Mosavi et al., “The Ankyrin Repeat as Molecular Architecture for Protein Recognition,” Protein Sci. 13:1435-1448, 2004.
Myilyharju et al., “Collagens and Collagen-Related Diseases,” Ann. Med. 33:7-21, 2001.
Nwogu et al., “Inhibition of Collagen Synthesis with Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation after Myocardial Infarction,” Circulation 104:2216-2221, 2001.
Ohta et al., “The Absolute Configuration of P-1894B, A Potent Prolyl Hydroxylase Inhibitor,” Chem. and Pharm. Bulletin 32:4350-4359, 1984.
Philipp et al., “Prolyl 4-Hydroxylase Inhibition Induces HIF and Improved Cardiac Function after Myocardial Infarction,” Circulation 106 (Suppl. S.):II-267, Abstract No. 1344, 2002 (Abstract only).
Schultz et al., “Smart, a Simple Modular Architecture Research Tool: Identification of Signaling Domains,” Proc. Natl. Acad. Sci. U.S.A. 95:5857-5864, 1998.
Wang et al., “Structure ofAquifex AeolicusKDO8P Synthase in Complex with R5P and PEP, and with a Bisubstrate Inhibitor: Role of Active Site Water in Catalysis,” Biochem. 40:15676-15683, 2001.
Wu et al., “Mechanism-Based Inactivation of the Human Prolyl-4-Hydroxylase by 5-Oxaproline-Containing Peptides: Evidence for a Prolyl Radical Intermediate,” J. Am. Chem. Soc. 121:587-588, 1999.
International Preliminary Report on Patentability from International Application No. PCT/GB2005/001150, Nov. 15, 2005.
Cockman Matthew Edward
Hewitson Kirsty Sarah
Masson Norma
McDonough Michael Arnold
Ratcliffe Peter John
Clark & Elbing LLP
Isis Innovation Limited
Martin Paul C.
Weber Jon P
LandOfFree
Assays for identifying modulators of the hydroxylation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assays for identifying modulators of the hydroxylation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assays for identifying modulators of the hydroxylation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4117191